|
|
|
LifeScienceHistory.com - Check us out on Instagram
New York Life Science Industry Directory
Banner Advertising
Please note that we have a new site: LifeScienceHistory.com, "Where history is made daily" under development and
delayed by COVID-19, to be launched in 2023 replacing New YorkLifeScience.com. Regrettably, we are working with reduced
staffing and the current industry directory is no longer being maintained, but will be replaced with a new and improved
directory upon the launch of the new site. We apologize for the inconvenience.
Abeona Therapeutics
| | | Phone: | (216) 287-5408 | Year Established: | 2013 | Ticker: | ABEO | Exchange: | NASDAQ | Main Contact: | João Siffert, M.D., Interim CEO | | Other Contacts: | Kaye Spratt, Ph.D., VP, Regulatory & Quality Assurance Michelle Berg, VP, Patient Advocacy Jeffrey B. Davis, COO Stephen B. Thompson, CAO Max Colao, CCO Magdalena Tyrpien, Diector, Corporate Strategy Juan Ruiz, M.D., Ph.D., Head of European Medical Affairs Neena Patil, J.D., General Counsel
| | Company Description | Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups. Abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases such as Sanfilippo disorder, Batten disease, Fanconi anemia and other rare disorders. | |
|
|
|
|
|